Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI South Korea ETF (EWY) vs ImmunityBio Inc. Common Stock (IBRX) Price & Performance

iShares MSCI South Korea ETFTrade
ImmunityBio Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI South Korea ETF vs ImmunityBio Inc. Common Stock — how do they compare? iShares MSCI South Korea ETF trades at $176.88 (market cap $26.25B), while ImmunityBio Inc. Common Stock trades at $10.6 (market cap $10.51B). The key difference: iShares MSCI South Korea ETF is far larger — about 2.5× ImmunityBio Inc. Common Stock's market cap, and ImmunityBio Inc. Common Stock is trading nearer its 52-week high, iShares MSCI South Korea ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI South Korea ETF for 47 Days and ImmunityBio Inc. Common Stock for 1 Days on average.

EWYIBRX
Market Cap
$26.25B$10.51B
Volume
19,056,07510,445,785
Sector
Broad Market / FactorHealth
52-Week High
$219.20$11.55
52-Week Low
$80.72$1.98
Typical Hold Time
47 Days1 Days
Enterprise Value
—$10.97B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI South Korea ETF

EWY (iShares MSCI South Korea ETF) is trading at $177.18, down 3.56% amid broad Asian market weakness driven by rising oil prices and global bond yields. The ETF shows a bearish technical signal with moving averages indicating selling pressure, though RSI levels suggest potential oversold conditions. Recent news highlights South Korea's KOSPI volatility, with semiconductor stocks facing pressure despite strong AI demand fundamentals and corporate earnings resilience.

The outlook remains cautious due to concentrated exposure to Samsung and SK hynix, making EWY highly sensitive to memory cycle trends. While AI infrastructure spending provides long-term growth potential, near-term risks include rising borrowing costs, oil price volatility, and geopolitical tensions. The ETF's heavy technology weighting creates both opportunity and vulnerability to sector-specific headwinds.

ImmunityBio Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

EWY
54% Buy46% Sell
Avg holding period · 47 Days
IBRX

No sentiment data available yet.

About iShares MSCI South Korea ETF

EWY tracks the MSCI Korea 25/50 Index, offering targeted exposure to large and mid-cap companies in South Korea. It is structurally centered on the global technology supply chain, industrials, and financial services, serving as a liquid tool for investors seeking a single-country view of this advanced, innovation-led economy.

Read more on EWY →

About ImmunityBio Inc. Common Stock

ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.

Read more on IBRX →